We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI (POSTCON II)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00835848
First Posted: February 4, 2009
Last Update Posted: May 5, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University Hospital, Gentofte, Copenhagen
Information provided by (Responsible Party):
Thomas Engstrom, Rigshospitalet, Denmark